Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors

Brain tumors, benign or malignant, are characterized by a very high degree of vascularization. Recent accumulating evidence suggests that during development the neuronal wiring follows the same routes as the vasculature and that these two systems may share some of the same factors for guidance. Thus, expression of dual angiogenic/neurogenic growth factors was evaluated by insitu hybridization in human primary brain tumors of three different types, i.e., astrocytomas, oligodendrogliomas, and ependymomas, of increasing grades, in relation with the grade and type of the tumor. For this evaluation we selected vascular endothelial growth factor (VEGF-A) and its receptors VEGF-R1 and VEGF-R2 and the neuropilins1 and 2 (NRP-1 and NRP-2), which have proangiogenic properties, platelet-derived growth factor (PDGF) receptor-beta (PDGF-Rβ), which is required for the functional maturation of blood vessels, the ephrins and their Eph receptors, angiotensinogen (AGT) and thrombospondin-2 (TSP-2), which have potential antiangiogenic properties, and netrin-1 (Net-1), which regulates vascular architecture. We show that the expression of the VEGF-NRP system, PDGF-Rβ, TSP-2, AGT, and Net-1 are differentially regulated, either increased or decreased, in relation with the type and grade of the tumor, whereas regulation of the ephrinB system does not seem to be relevant in these human brain tumor

Angiopoietin 2 Alters Pancreatic Vascularization in Diabetic Conditions

Islet vascularization, by controlling beta-cell mass expansion in response to increased insulin demand, is implicated in the progression to glucose intolerance and type 2 diabetes. We investigated how hyperglycaemia impairs expansion and differentiation of the growing pancreas. We have grafted xenogenic (avian) embryonic pancreas in severe combined immuno-deficient (SCID) mouse and analyzed endocrine and endothelial development in hyperglycaemic compared to normoglycaemic conditions. 14 dpi chicken pancreases were grafted under the kidney capsule of normoglycaemic or hyperglycaemic, streptozotocin-induced, SCID mice and analyzed two weeks later. Vascularization was analyzed both quantitatively and qualitatively using either in situ hybridization with both mouse- and chick-specific RNA probes for VEGFR2 or immunohistochemistry with an antibody to nestin, a marker of endothelial cells that is specific for murine cells. To inhibit angiopoietin 2 (Ang2), SCID mice were treated with 4 mg/kg IP L1-10 twice/week. In normoglycaemic condition, chicken-derived endocrine and exocrine cells developed well and intragraft vessels were lined with mouse endothelial cells. When pancreases were grafted in hyperglycaemic mice, growth and differentiation of the graft were altered and we observed endothelial discontinuities, large blood-filled spaces. Vessel density was decreased. These major vascular anomalies were associated with strong over-expression of chick-Ang2. To explore the possibility that Ang2 over-expression could be a key step in vascular disorganization induced by hyperglycaemia, we treated mice with L1-10, an Ang-2 specific inhibitor. Inhibition of Ang2 improved vascularization and beta-cell density. this work highligghted an important role of Ang2 in pancreatic vascular defects induced by hyperglycemia

A chicken model of pharmacologically-induced Hirschsprung disease reveals an unexpected role of glucocorticoids in enteric aganglionosis

International audienceThe enteric nervous system originates from neural crest cells that migrate in chains as they colonize the embryonic gut, eventually forming the myenteric and submucosal plexus. Failure of the neural crest cells to colonize the gut leads to aganglionosis in the terminal gut, a pathological condition called Hirschsprung disease (HSCR) in humans, also known as congenital megacolon or intestinal aganglionosis. One of the characteristics of the human HSCR is its variable penetrance, which may be attributable to the interaction between genetic factors, such as the endothelin-3/endothelin receptor B pathway, and non-genetic modulators, although the role of the latter has not well been established. We have created a novel HSCR model in the chick embryo allowing to test the ability of non-genetic modifiers to alter the HSCR phenotype. Chick embryos treated by phosphoramidon, which blocks the generation of endothelin-3, failed to develop enteric ganglia in the very distal bowel, characteristic of an HSCR-like phenotype. Administration of dexamethasone influenced the phenotype, suggesting that glucocorticoids may be environmental modulators of the penetrance of the aganglionosis in HSCR disease

Régulation de la croissance : des mécanismes épigénétiques ?

International audienceOrganism development is controlled by both genetic programs and the environment to insure a reproductive success as adults. Linear growth is an important part of the development and is mostly controlled by genetic factors. However, the variability of height in a given species does not seem to be specifically associated with SNP. This suggests that environment may play a crucial role. In agreement, an important part of height-related genes present CpG island in their proximal promoter, indicating potential involvement of epigenetic mechanisms. In mammals, the linear growth is regulated by the IGF system, with IGF-I and IGF-II during the fetal period, and IGF-I being included within the somatotropic axis during the postnatal period. Nutrition during the lactating period programs linear growth and adult size through a modulation of the somatotropic axis development and of the setting of its activity later on. The study of underlying mechanisms suggest two waves of programming, which involve both structural adaptation during the early postnatal period and permanent functional adaptation in adulthood. The former may involve a direct stimulation of axon growth of GHRH neurons by IGF-I in first weeks of life while the latter could involve permanent epigenetic modifications in adulthood.Le développement de l’organisme est contrôlé à la fois par des programmes génétiques et par l’environnement afin d’assurer un succès reproductif à l’âge adulte. La croissance staturale est une partie importante du développement et est principalement contrôlée par des facteurs génétiques. Cependant, la variabilité de la taille chez une espèce donnée ne semble pas être entièrement sous la dépendance du background génétique. Ceci suggère que l’environnement pourrait jouer un rôle crucial. En accord avec cela, une proportion importante des gènes liés à la croissance présente un îlot CpG dans leur promoteur proximal, ce qui indique l’implication potentielle de mécanismes épigénétiques. Chez les mammifères, la croissance staturale est régulée par le système IGF, avec l’IGF-I et IGF-II durant la période fœtale et l’IGF-I étant inclus dans l’axe somatotrope lors la période postnatale. La nutrition pendant la période transitoire qu’est l’allaitement programme la croissance staturale et la taille adulte par une modulation du développement de l’axe somatotrope et de son activité à l’âge adulte. L’étude des mécanismes sous-jacents suggère deux vagues de programmation, qui impliquent à la fois une adaptation structurelle en période postnatale précoce et une adaptation fonctionnelle permanente chez l’adulte. La première semble impliquer une stimulation directe de la croissance axonale des neurones GHRH par l’IGF-I dans les premières semaines de vie, alors que la seconde pourrait impliquer des modifications épigénétiques permanentes à l’âge adulte

Régulation de la croissance : des mécanismes épigénétiques ?

International audienceOrganism development is controlled by both genetic programs and the environment to insure a reproductive success as adults. Linear growth is an important part of the development and is mostly controlled by genetic factors. However, the variability of height in a given species does not seem to be specifically associated with SNP. This suggests that environment may play a crucial role. In agreement, an important part of height-related genes present CpG island in their proximal promoter, indicating potential involvement of epigenetic mechanisms. In mammals, the linear growth is regulated by the IGF system, with IGF-I and IGF-II during the fetal period, and IGF-I being included within the somatotropic axis during the postnatal period. Nutrition during the lactating period programs linear growth and adult size through a modulation of the somatotropic axis development and of the setting of its activity later on. The study of underlying mechanisms suggest two waves of programming, which involve both structural adaptation during the early postnatal period and permanent functional adaptation in adulthood. The former may involve a direct stimulation of axon growth of GHRH neurons by IGF-I in first weeks of life while the latter could involve permanent epigenetic modifications in adulthood.Le développement de l’organisme est contrôlé à la fois par des programmes génétiques et par l’environnement afin d’assurer un succès reproductif à l’âge adulte. La croissance staturale est une partie importante du développement et est principalement contrôlée par des facteurs génétiques. Cependant, la variabilité de la taille chez une espèce donnée ne semble pas être entièrement sous la dépendance du background génétique. Ceci suggère que l’environnement pourrait jouer un rôle crucial. En accord avec cela, une proportion importante des gènes liés à la croissance présente un îlot CpG dans leur promoteur proximal, ce qui indique l’implication potentielle de mécanismes épigénétiques. Chez les mammifères, la croissance staturale est régulée par le système IGF, avec l’IGF-I et IGF-II durant la période fœtale et l’IGF-I étant inclus dans l’axe somatotrope lors la période postnatale. La nutrition pendant la période transitoire qu’est l’allaitement programme la croissance staturale et la taille adulte par une modulation du développement de l’axe somatotrope et de son activité à l’âge adulte. L’étude des mécanismes sous-jacents suggère deux vagues de programmation, qui impliquent à la fois une adaptation structurelle en période postnatale précoce et une adaptation fonctionnelle permanente chez l’adulte. La première semble impliquer une stimulation directe de la croissance axonale des neurones GHRH par l’IGF-I dans les premières semaines de vie, alors que la seconde pourrait impliquer des modifications épigénétiques permanentes à l’âge adulte

<i>In situ</i> hybridization of angiogenic factors in pancreatic grafts after 2 weeks hyperglycaemia.

<p>Expression of mouse VEGF (A, B), chick VEGF (D, E), mouse Ang2 (G, H) and chick Ang2 (J, K) probes in normoglycemic (A, D, G, J) and hyperglycaemic grafts (B, E, H, K) was analyzed by <i>in situ</i> hybridization. C, F, I and L, semi-quantification of labeling intensity between normoglycaemic and hyperglycaemic conditions. Ang2 expressions were increased by hyperglycaemia. Student <i>t</i>-test, **p<0.01, ***p<0.001, n = 5.</p